These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 6528554

  • 1. [Use of komplamin in chronic ischemic heart disease].
    Serkova VK, Mikunis RI.
    Vrach Delo; 1984 Nov; (11):16-8. PubMed ID: 6528554
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of complamine on various indicators of hemostasis and microcirculation in chronic ischemic heart disease].
    Bol'shakova RM, Dukhina MA, Furkalo NK, Solovtsova KM, Progonnaia VV.
    Vrach Delo; 1978 Jan; (1):36-40. PubMed ID: 625941
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of fenicaberan and xavin on peripheral hemodynamic and blood coagulability indices in patients with chronic ischemic heart disease].
    Shpak BIu, Neĭko EM, Debenklo MV, Lazho AS, Duma ZV.
    Vrach Delo; 1988 Mar; (3):34-6. PubMed ID: 3394293
    [No Abstract] [Full Text] [Related]

  • 4. [Therapeutic effect of complamine in atherosclerosis and ischemic heart disease].
    Kalmykova VI, Aronchuk EK.
    Sov Med; 1976 Jan; (1):113-8. PubMed ID: 1273633
    [No Abstract] [Full Text] [Related]

  • 5. [Ergometric evaluation of treatment of ischemic heart disease with xavine].
    Zadionchenko VS, Vertkin AL, Martynov AI, Panchenkova LA, Troshina EV.
    Sov Med; 1978 Jan; (1):68-73. PubMed ID: 635674
    [No Abstract] [Full Text] [Related]

  • 6. [Use of xanthinol nicotinate in patients with chronic ischemic heart disease].
    Sivkov II, Kukes VG, Borisov VG, Rudakov MA, Blistanova LS.
    Ter Arkh; 1977 Jan; 49(1):30-3. PubMed ID: 867235
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of the efficacy of xavin treatment of ischemic heart disease].
    Pomerantsev VP, Ivanova NA, Zadionchenko VS, Vertkin AL, Martynov AI.
    Kardiologiia; 1978 Mar; 18(3):36-43. PubMed ID: 347136
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effectiveness of the local use of komplamin and ATP in treating patients with primary and secondary optic atrophy].
    Shpak NI, Fedorova LI, Savko VV, Konovalova NV.
    Oftalmol Zh; 1985 Mar; (3):159-62. PubMed ID: 4011098
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
    Musil HE.
    Med Welt; 1973 Jan 19; 24(3):103-13. PubMed ID: 4617835
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of complamin on the levels of ACTH, cortisol and lipids in the blood of elderly patients with ischemic heart disease].
    Gorbachev VV, Pristrom MS.
    Kardiologiia; 1986 May 19; 26(5):30-3. PubMed ID: 3016399
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Use of complamin in nephrological practice].
    Mamikonian RS, Barsegian BA, Tumanian AM, Arutiunian VM, Basmadzhian NM.
    Zh Eksp Klin Med; 1979 May 19; 19(4):62-7. PubMed ID: 506579
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.